Picture of BioAffinity Technologies logo

BIAF — BioAffinity Technologies News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareMicro CapNeutral

Brief: Bioaffinity Technologies Reports Q3 Results, Provides Business Update

Nov 14 (Reuters) - bioAffinity Technologies Inc
 BIAF.O :
    * BIOAFFINITY TECHNOLOGIES REPORTS THIRD QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
    * BIOAFFINITY TECHNOLOGIES INC - QTRLY LOSS PER SHARE $1.10
    * BIOAFFINITY TECHNOLOGIES INC - CO ON TRACK TO EXPAND
MARKETING
OUTREACH FOR ITS INITIAL PRODUCT, CYPATH® LUNG, THAT DETECTS
EARLY-STAGE LUNG CANCER

Source text for Eikon:  ID:nBw9MyPSKa 
Further company coverage:  BIAF.O

Recent news on BioAffinity Technologies

See all news